Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

BNTC holding history

Benitec Biopharma Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BNTC overviewAll 13F holders of BNTCFull Q2 2026 holdings

Shares (Q2 2026)
125,431
Value
$1.68M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BNTC by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026125,431$1.68M<0.1%+9,612+8.3%AddedHolders
Q1 2026115,819$1.23M<0.1%+17,472+17.8%AddedHolders
Q4 202598,347$1.32M<0.1%−1,594−1.6%ReducedHolders
Q3 202599,941$1.40M<0.1%+82,057+458.8%AddedHolders
Q2 202517,884$209.2K<0.1%+7,872+78.6%AddedHolders
Q1 202510,012$130.3K<0.1%+4,999+99.7%AddedHolders
Q4 20245,013$63.3K<0.1%+3,089+160.6%AddedHolders
Q3 20241,924$17.7K<0.1%−108−5.3%ReducedHolders
Q2 20242,032$14.2K<0.1%+1,520+296.9%AddedHolders
Q1 2024512$2.69K<0.1%−110−17.7%ReducedHolders
Q4 2023622$2.01K<0.1%+513+470.6%AddedHolders
Q3 2023109$329<0.1%+89+434.0%AddedConverted for a 1-for-17 splitHolders
Q2 2023347$82<0.1%00.0%UnchangedHolders
Q1 2023347$73<0.1%−927−72.8%ReducedHolders
Q4 20221,274$217<0.1%−27,409−95.6%ReducedHolders
Q3 202228,683$11.0K<0.1%+16,767+140.7%AddedHolders
Q2 202211,916$13.0K<0.1%+11,569+3,334.0%AddedHolders
Q1 2022347$1.00K<0.1%−2,759−88.8%ReducedHolders
Q4 20213,106$8.00K<0.1%+2,045+192.7%AddedHolders
Q3 20211,061$4.00K<0.1%+757+249.0%AddedHolders
Q2 2021304$1.00K<0.1%−1,147−79.0%ReducedHolders
Q1 20211,451$8.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.